首页> 外国专利> Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth

Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth

机译：加强和评估结肠对艰难梭菌过度生长的自然防御的方法

页面导航

摘要
著录项
相似文献

摘要

The present invention is related to a new probiotic composition or food product wherein such a composition or product comprises Clostridim bifermentans. Such a composition or product can be advantageously used to prevent or treat a gut infection with Clostridium difficile.;Also part of the invention is formed by methods for assaying for C. bifermentans, for establishing the infective state of a subject by assaying for the presence of C. bifermentans, and by predicting the risk of overgrowth of C. difficile resulting from an antibiotic treatment before start of that treatment.

机译：本发明涉及一种新的益生菌组合物或食品，其中该组合物或产品包含Clostridim bifermentans。该组合物或产品可以有利地用于预防或治疗肠感染。艰难梭菌。本发明的一部分还通过测定 C 的方法形成。双歧杆菌，用于通过检测 C 的存在来建立对象的感染状态。双歧杆菌，并通过预测 C过度生长的风险。在开始治疗前因抗生素治疗而引起的难治性病。 展开▼

著录项

公开/公告号EP2684469A1

专利类型

公开/公告日2014-01-15

原文格式PDF

申请/专利权人 NEDERLANDSE ORGANISATIE VOOR TOEGEPAST -NATUURWETENSCHAPPELIJK ONDERZOEK TNO;
展开▼

申请/专利号EP20120176300

发明设计人 BRUNNER JORG;MONTIJN ROY CHRISTIAAN;KEIJSER BART JAN FREDERIK;SCHUREN FRANK HENRI JOHAN;
展开▼

申请日2012-07-13

分类号A23L1/30;A61K35/74;

国家 EP

入库时间 2022-08-21 15:47:20

相似文献

专利

外文文献

中文文献

1. 检测和分析艰难梭菌菌株的组合物和试剂盒及用该组合物和试剂盒检测艰难梭菌菌株的方法 [P] . 中国专利： CN103484532A . 2014-01-01

2. 抗艰难梭菌毒素卵黄抗体IgY结肠定位制剂 [P] . 中国专利： CN106474469B . 2021.07.09

3. isolated human monoclonal antibody or antigen-binding part thereof, isolated polypeptide, composition, isolated nucleic acid, expression vector, host cell, kit, and, methods for treating c. difficile in an individual and to treat a disease or disorder associated with c. difficile in a mammal [P] . BRPI0507433A . 2007-07-03

机译：分离的人单克隆抗体或其抗原结合部分，分离的多肽，组合物，分离的核酸，表达载体，宿主细胞，试剂盒以及治疗c的方法。使个体难治并治疗与c相关的疾病或病症。在哺乳动物中难辨

4. 9- (2- phosphonate nilme methoxyethyl) adenine, Ade Ade phobia phobia difficile C. difficile carboxylic acid and amorphous the method [P] . 韩国专利： KR101048024B1 . 2011-07-13

机译： 9-（2-膦酸酯nilme甲氧基乙基）腺嘌呤，Ade Ade phobia diffbiaile C. difficile羧酸和无定形的方法

5. Tetra-specific, octameric binding agents and antibodies against Clostridium difficile toxin A and toxin B for treatment of C. difficile infection [P] . US10961299B2 . 2021-03-30

机译： TETRA特异性的，八大聚酰胺结合剂和抗腹腹腹腹梭菌的抗体用于治疗 C的毒素A和毒素B.艰难岩感染

1. Structural failure mechanism and strengthening method of fracture plugging zone for lost circulation control in deep naturally fractured reservoirs [J] . XU Chengyuan, YAN Xiaopeng, KANG Yili, 石油勘探与开发:英文版 . 2020,第002期

2. Comparative assessment of the therapeutic drug targets of C. botulinum C. botulinum ATCC 3502 and C. difficile C. difficile str. 630 using in silico subtractive proteomics approach [J] . Bhardwaj Tulika, Haque Shafiul, Somvanshi Pallavi Journal of cellular biochemistry. . 2019,第9期

3. Ribotype variability of Clostridioides difficile strains in patients with hospital-acquired C. difficile infections, community-acquired C. difficile infections, and colonization with toxigenic and non-toxigenic strains of C. difficile [J] . Kim Bongyoung, Seo Mi-Ran, Kim Jieun, Anaerobe . 2019,第期

4. Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens [J] . Annals of laboratory medicine. . 2016,第2期

5. Handheld cold atmospheric air plasma pen and in vitro studies of M.R.S.A., C. difficile and A. baumannii decontamination [C] . OConnor Niall, Cahill Orla J., Galvin Sandra, 2012 Abstracts 39th IEEE International Conference on Plasma Science. . 2012

6. Experimental Clostridium difficile enterocolitis in foals and molecular typing of C. difficile isolates originating from different species and a teaching hospital environment. [D] . Arroyo Castro, Luis G. 2004

7. Evaluation of Xpert C. difficile BD MAX Cdiff IMDx C. difficile for Abbott m2000 and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens [O] . Bo-Moon Shin, Sun Mee Yoo, Won Chang Shin 2016

8. Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus helveticus CNCM I-1722 and Bifidobacterium longum subsp. longum CNCM I-3470 and alleviation of psychological stress (ID 938) and “maintains the balance of healthy microbiota that helps to strengthen the natural defence” (ID 2942) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 [O] . EFSA Panel on Dietetic Products, Nutrition and Allergies 2012

9. Evaluation and Research on Antimicrobial Stewardship's Effect on Clostridium difficile (ERASE C. difficile) Project. Toolkit for Reduction of Clostridium difficile through Antimicrobial Stewardship. [R] . 2012

1. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon [J] . Antonio Tursi ,Giovanni Brandimarte ,Gian Marco Giorgetti . 世界胃肠病学杂志：英文版 . 2005,第18期

2. Structural failure mechanism and strengthening method of fracture plugging zone for lost circulation control in deep naturally fractured reservoirs [J] . XU Chengyuan ,YAN Xiaopeng ,KANG Yili . 石油勘探与开发 . 2020,第002期

3. Development a Spectrophotometric of Fe(Ⅲ), Al(Ⅲ) and Cu(Ⅱ) Using Eriochrome Cyanine R Ligand and Assessment of the Obtained Data by Partial Least-Squares and Artificial Neural Network Method-Application to Natural Waters [J] . A. Hakan AKTAS . 光谱学与光谱分析 . 2018,第8期

4. Survey of iC. difficile/i-Specific Infection Control Policies in Local Long-Term Care Facilities [J] . Laurie Archbald-Pannone . 临床医学国际期刊（英文） . 2014,第7期

5. 一例难治性溃疡性结肠炎合并艰难梭菌感染的病例分析 [C] . . 2017中国临床药学学术年会暨第十三届中国临床药师论坛 . 2017

6. 血液病患者产毒艰难梭菌定植和感染危险因素的前瞻性研究及临床分离艰难梭菌的耐药性分析 [A] . 王洁 . 2014